HOME >> BIOLOGY >> NEWS
Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion

used to deliver cytokines to diseased target cells without the toxicities observed when cytokines are administered systemically.

Targeted Genetics has supported two Phase I studies of HIV-specific CTLs in HIV infected patients conducted by Riddell and Greenberg at the Hutchinson Center. Additional Phase I/II studies of adoptive immunotherapy using CTLs expanded with the REM technology are ongoing at the Hutchinson Center for the precaution of cytomegalovirus (CMV) disease in bone marrow transplant patients and for the treatment of patients with late stage melanoma Targeted Genetics has several issued and pending patents in this area. Prior to development of the REM technology, technical and regulatory hurdles made adoptive immunotherapy too costly for commercialization. Targeted Genetics has further developed this technology to facilitate commercial development by focusing on scalability of costs and reagents. Targeted Genetics has filed additional patents regarding improvements to the REM technology.

"In addition to its significant potential in adoptive immunotherapy, Targeted Genetics' REM technology also is a strategic core technology for research, development, and commercialization of other technologies aimed at treating chronic viral and malignant disease," said H. Stewart Parker, President and Chief Executive Officer of Targeted Genetics. "The REM process is applicable to broad-based technologies such as genomics and to the identification of new proteins or small molecules with therapeutic potential. This patent, in concert with Targeted Genetics' other patents and intellectual property, forms a powerful core technology platform either as a stand alone therapeutic or in concert with existing technologies."

Targeted Genetics Corporation develops gene and cell therapy products for the treatment of certain acquired and inherited diseases. The company has three lead development programs targeting cystic fibrosis, cancer, and infectious disease
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
27-Oct-1998


Page: 1 2 3

Related biology news :

1. Intel and Fred Hutchinson to explore the use of nanotechnology tools for early disease detection
2. American Association for Cancer Research honors Fred Hutchinson Cancer Research Center investigator
3. Fred Hutchinson Cancer Research Center, University of Washington join in national effort to study health impact of toxic substances
4. Hutchinson Center researchers first to induce state of suspended animation in model vertebrate organism
5. Digging for genetic fossils: Hutchinson Center researchers solve structure of ancient biological molecule
6. Fred Hutchinson Cancer Research Center to lead international team to accelerate investigation of immune-related genes
7. Hutchinson Center researcher awarded Block lectureship
8. White House honors Hutchinson Center Scientist with Presidential Early Career Award
9. Hutchinson Center to lead $11.5 million ovarian-cancer research consortium
10. Fred Hutchinson Cancer Research Center researcher one of five awarded $1 million distinguished young scholars grant
11. Hutchinson Center Director Wins Americas Nobel

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
Cached News: